Ser214
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser214  -  14-3-3 theta (human)

Site Information
AMBIGUOUS SITES: 14‑3‑3 beta (human): , 14‑3‑3 epsilon (human): , 14‑3‑3 eta (human): , 14‑3‑3 gamma (human): , 14‑3‑3 sigma (human): , 14‑3‑3 zeta (human):
NEDsykDstLIMQLL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 31864002

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 )
Disease tissue studied:
lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:

References 

1

Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68
22617229   Curated Info